Showing results (251-260 of 634) with videos related to

Sort By:
Pageof 64
World Journal of Emergency Surgery : WJES|June 10, 2009
Alteration in emergency theatre prioritisation does not alter outcome for acute appendicitis: comparative cohort studyStefano Partelli, Sabina Beg, Juliette Brown, et al.
Gastroenterology|July 17, 2007
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resectionJ Ruben Rodriguez, Roberto Salvia, Stefano Crippa, et al.
Annals of Surgical Oncology|July 24, 2023
Detecting Somatic Mutations for Well-Differentiated Pancreatic Neuroendocrine Tumors in Endoscopic Ultrasound-Guided Fine Needle Aspiration with Next-Generation SequencingElie M Ghabi, Joseph R Habib, Sami Shoucair, et al.
The British Journal of Surgery|May 20, 2022
Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumoursClaudio Ricci, Stefano Partelli, Luca Landoni, et al.
Ebiomedicine|September 30, 2023
Pro-tumor Tfh2 cells induce detrimental IgG4 production and PGE2-dependent IgE inhibition in pancreatic cancerLucia De Monte, Francesca Clemente, Eliana Ruggiero, et al.
United European Gastroenterology Journal|July 27, 2022
Risk factors for the occurrence of ampullary tumors: A case-control studyPiera Zaccari, Livia Archibugi, Giulio Belfiori, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 30, 2011
B-cell lymphoma presenting as acute pancreatitisEdda Federico, Massimo Falconi, Gianni Zuodar, et al.
Updates in Surgery|July 28, 2021
Total pancreatectomy sequelae and quality of life: results of islet autotransplantation as a possible mitigation strategyFrancesca Aleotti, Rita Nano, Lorenzo Piemonti, et al.
Carcinogenesis|June 8, 2022
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNsMatteo Giaccherini, Manuel Gentiluomo, Paolo Giorgio Arcidiacono, et al.
Cancers|October 13, 2021
EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs)Simon Leonhard April-Monn, Valentina Andreasi, Marco Schiavo Lena, et al.
Pageof 64